Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting

-Factor advances next-generation allogeneic and in vivo CAR-T cell therapy programs -Presentations will include latest data from Factor's IL12-expressing iMacrophages for treating solid tumors (FACT-112), as well as recent advances in Factor's RNA-based cell reprogramming technologies...